Back To: Home : Featured Technology : Reagents/Proteins

CLICK HERE FOR WHAT'S NEW IN:
 

BD secures license to Asuragenís MDx technology
August 2012
SHARING OPTIONS:

AUSTIN, TexasóAsuragen Inc. recently announced that it has granted Becton, Dickinson and Co. (BD) non-exclusive worldwide rights to incorporate Armored RNA technology into its in-vitro molecular diagnostics products. Armored RNA, jointly invented and developed by Asuragen and Cenetron Diagnostics, is a franchise technology for creating RNA and DNA standards for molecular diagnostic assays. Per the terms of the agreement, Asuragen will develop and supply reagents for BD Diagnostics. Financial terms  and other details were not disclosed.  
 
"We're pleased that yet another worldwide leader in molecular diagnostics has chosen Armored RNA technology for its in-vitro molecular diagnostic kits. Armored RNA controls, due to the nature of their reliability and integrity, have become the industry standard in a wide range of diagnostic tests," said Dr. Matt Winkler, CEO of Asuragen.        
 

Back

PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.